Klaus Duecker

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 1

Top Topics

Replacement Therapy

Randomized Controlled Trial

Top Venues

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Michael A Carducci, Ding Wang, Christina Habermehl, Matthias Bödding, Felix Rohdich, Floriane Lignet, Klaus Duecker, Oleksandr Karpenko, Linda Pudelko, Claude Gimmi, Patricia M LoRusso
A First-in-human, Dose-escalation Study of the Methionine Aminopeptidase 2 Inhibitor M8891 in Patients with Advanced Solid Tumors. Cancer research communications 3 (8) (2023)